Matches in SemOpenAlex for { <https://semopenalex.org/work/W3083536005> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- W3083536005 abstract "Objective: The delivery of drugs and immune cells into the tumor microenvironment is limited due to abnormal tumor vessel which is characterized as low oxygen concentration, low perfusion rate and leakage. It leads to diminish the efficacy of drugs and radiation therapy. Traditional anti-angiogenesis strategies attempt to reduce the tumor vascular supply, but their success is restricted by insufficient efficacy or development of resistance. To solve the problem, we try to using active vessel stabilizer, which can normalize the abnormal condition of tumor vessel. Background: Tie2 acts as cell-surface receptor for Ang1/Ang2 and regulates angiogenesis, endothelial cell survival, proliferation, migration, as well as maintenance of vascular quiescence. Especially, Ang1-Tie2 signaling pathway has been known to promote blood vessel maturation and stabilization. Methods: We have developed a series of novel human IgG monoclonal antibody that binds to human-TIE2 with a high affinity (Kd ~0.1 nM). The antibody binds to human TIE2 extracellular domain and activates its associated function in a ligand independent way. The mode of action was studied in vitro with human umbilical vein endothelial cells (HUVEC) and animal models. The vessel stabilization was investigated with laser induced choroidal neovascularization (CNV). The effect on tumor infiltrated lymphocyte was also studied in mouse colon cancer model. Results: Anti-Tie2 antibody increased human endothelial cell migration like Ang1 and inhibited VEGF-induced vascular leakage, contributing to vessel normalization. It binds to Tie2 in a ligand independent way and thus it can stabilize vessel as an agonist. Both p-VEGFR and p-VE-Cadherin levels are also significantly decreased on VEGF-induced VEGFR signaling pathway by anti-Tie2 antibody, suggesting that it can maintain cell to cell junction. The vessel stabilization effect was demonstrated in a mouse model of laser induced CNV. Moreover, in syngeneic CT26 mouse models, anti-Tie2 antibody showed anti-tumor effect in which it significantly reduced the tumor growth and synergistically when it combined with anti PD-1 antibody. The tumor infiltrating lymphocytes were increased in CT26 tumor, especially CD8+ T cells and MDSC when anti-Tie2 was administered. Conclusion: We developed active vessels stabilizer targeting Tie2, having an effect of vessel stabilization in a ligand independent way. It inhibited VEGF-induced vascular leakage through decrease of p-VEGFR and VE-cadherin. This active vessel stabilizer could help deliver drug and lymphocyte into the TME. The therapeutic efficacy of immune checkpoint inhibitors can be increased when it combined with this active vessel stabilizer. Thus, this active vessel stabilizer can change cold tumor into hot tumor. Citation Format: Eun-Ah Lee, Beomyong Park, Nu Ri Kang, Youngae Lee, Do-yun Kim, Sang Soon Byun, Jin Yong An, Cheon Ho Park, Weon Sup Lee, Joo Hyoung Lee. A novel anti-Tie2 antibody stabilizes vessel and increases tumor infiltrated lymphocytes [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 1483." @default.
- W3083536005 created "2020-09-11" @default.
- W3083536005 creator A5006437153 @default.
- W3083536005 creator A5021110872 @default.
- W3083536005 creator A5022475656 @default.
- W3083536005 creator A5031631714 @default.
- W3083536005 creator A5040720866 @default.
- W3083536005 creator A5048664144 @default.
- W3083536005 creator A5062080530 @default.
- W3083536005 creator A5066386015 @default.
- W3083536005 creator A5068611232 @default.
- W3083536005 creator A5086449439 @default.
- W3083536005 date "2020-08-13" @default.
- W3083536005 modified "2023-10-15" @default.
- W3083536005 title "Abstract 1483: A novel anti-Tie2 antibody stabilizes vessel and increases tumor infiltrated lymphocytes" @default.
- W3083536005 doi "https://doi.org/10.1158/1538-7445.am2020-1483" @default.
- W3083536005 hasPublicationYear "2020" @default.
- W3083536005 type Work @default.
- W3083536005 sameAs 3083536005 @default.
- W3083536005 citedByCount "0" @default.
- W3083536005 crossrefType "proceedings-article" @default.
- W3083536005 hasAuthorship W3083536005A5006437153 @default.
- W3083536005 hasAuthorship W3083536005A5021110872 @default.
- W3083536005 hasAuthorship W3083536005A5022475656 @default.
- W3083536005 hasAuthorship W3083536005A5031631714 @default.
- W3083536005 hasAuthorship W3083536005A5040720866 @default.
- W3083536005 hasAuthorship W3083536005A5048664144 @default.
- W3083536005 hasAuthorship W3083536005A5062080530 @default.
- W3083536005 hasAuthorship W3083536005A5066386015 @default.
- W3083536005 hasAuthorship W3083536005A5068611232 @default.
- W3083536005 hasAuthorship W3083536005A5086449439 @default.
- W3083536005 hasBestOaLocation W30835360051 @default.
- W3083536005 hasConcept C159654299 @default.
- W3083536005 hasConcept C203014093 @default.
- W3083536005 hasConcept C2780394083 @default.
- W3083536005 hasConcept C502942594 @default.
- W3083536005 hasConcept C71924100 @default.
- W3083536005 hasConcept C85219853 @default.
- W3083536005 hasConceptScore W3083536005C159654299 @default.
- W3083536005 hasConceptScore W3083536005C203014093 @default.
- W3083536005 hasConceptScore W3083536005C2780394083 @default.
- W3083536005 hasConceptScore W3083536005C502942594 @default.
- W3083536005 hasConceptScore W3083536005C71924100 @default.
- W3083536005 hasConceptScore W3083536005C85219853 @default.
- W3083536005 hasLocation W30835360051 @default.
- W3083536005 hasOpenAccess W3083536005 @default.
- W3083536005 hasPrimaryLocation W30835360051 @default.
- W3083536005 hasRelatedWork W1996526210 @default.
- W3083536005 hasRelatedWork W2049834005 @default.
- W3083536005 hasRelatedWork W2092783623 @default.
- W3083536005 hasRelatedWork W2135769591 @default.
- W3083536005 hasRelatedWork W2479365944 @default.
- W3083536005 hasRelatedWork W2745510155 @default.
- W3083536005 hasRelatedWork W2767866126 @default.
- W3083536005 hasRelatedWork W4221114878 @default.
- W3083536005 hasRelatedWork W4362493426 @default.
- W3083536005 hasRelatedWork W89533997 @default.
- W3083536005 isParatext "false" @default.
- W3083536005 isRetracted "false" @default.
- W3083536005 magId "3083536005" @default.
- W3083536005 workType "article" @default.